ENTPD2 and colonic neoplasm: The ATP hydrolysis assay revealed that ENTPD2 knockdown (RKO-shENTPD2 and DLD1-shENTPD2 cells) severely impaired the ability of colon cancer cells to degrade extracellular ATP (P < 0.05, Fig. 2A-B).